Skip to main content
Caplight Logo









Xsphera Biosciences

Xsphera Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.xspherabio.com/

Last Round

Seed

Jun 15, 2022

Total Funding Raised

$481,800

Company Overview

Xsphera Biosciences is a biotechnology company that provides a fresh human tumor tissue-based platform for oncology therapeutic testing and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

ex vivo tumor modelimmuno-oncologydrug discoveryprecision medicinecontract research organizationCROtumor microenvironmentpatient-derived tissueorganoidpre-clinical researchtranslational researchdrug efficacy testinghigh-content screeninglab-on-a-chipbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xsphera Biosciences Comparables

Compare Xsphera Biosciences with similar companies based on industry and business-model similarity.

Xsphera Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VitroScan
89%
Kiyatec
88%
Xilis
87%

Xsphera Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 15, 2022
GrantDec 12, 2019

Key People

Founding team and executive leadership

Stephen Remondi

CEO Founder

Founding Team

Kevin Horrigan

Chief Technology Officer

Executive Team

Xsphera Biosciences Investors

Notable investors and investment history

Xsphera Biosciences investors
InvestorRounds
U.S. Department of Health and Human ServicesGrant
Aquila Capital PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 764% MoM, reaching 1.4K.

  • Jun 15, 2022

    $100K round led by Aquila Capital Partners.

Xsphera Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xsphera Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xsphera Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range14
Year Founded2018
Last FundingJun 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?